Return to News Categories

ALL NEWS SECTIONS:
MOST POPULAR SECTIONS:
Commentary and Educational Cattle - Hogs / Livestock News Currencies News Energy News Grain News Index News Interest Futures News Metals Futures News Reports: Crops, CFTC, etc Soft Commodities News

Futures and Commodity Market News

Veterinary/Animal Vaccines Market by Type, Disease & Technology - Global Forecast to 2022 - Research and Markets

DUBLIN, Nov 10, 2017 (BUSINESS WIRE) --

The "Veterinary/Animal Vaccines Market - Global Forecast to 2022" report has been added to Research and Markets' offering.

The global veterinary vaccines market is projected to reach USD 8.66 Billion by 2022 from USD 6.50 Billion in 2017, at a CAGR of 5.9% during the forecast period (2017-2022).

Market growth can be attributed to factors such as growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines in the market. On the other hand, the high storage cost for vaccines is expected to restrain the market to a certain extent.

On the basis of type, the veterinary vaccines market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and other vaccines. The companion animal vaccines segment is divided into canine vaccines and feline vaccines and in terms of value, the companion animal vaccines segment is expected grow at the highest CAGR during the forecast period. Increasing awareness about companion animal vaccination, rising prevalence of zoonotic diseases in humans, and the growing number of pets and increasing pet ownership are fueling the demand for these vaccines.

By technology, the market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines. In terms of value, the live attenuated vaccines segment is expected to account for the largest share of the market in 2017. The ease of administration and long-term immunity offered by the live attenuated vaccine technologies are driving the demand for this segment in the veterinary vaccines industry.

Companies Mentioned:

Biogenesis Bago Boehringer Ingelheim Ceva China Animal Husbandry Elanco Hester Hipra IDT Biologika Jinyu Bio-Technology Merck Animal Health Phibro Animal Health Tianjin Ringpu Vetoquinol Virbac Zoetis

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Veterinary Vaccines Market, By Type

7 Veterinary Vaccines Market, By Disease

8 Veterinary Vaccines Market, By Technology

9 Veterinary Vaccines Market, By Region

10 Competitive Landscape

11 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/mnksj7/veterinaryanimal

http://cts.businesswire.com/ct/CT?id=bwnews&sty=20171110005268r1&sid=cmtx6&distro=nx&lang=en

View source version on businesswire.com: http://www.businesswire.com/news/home/20171110005268/en/

SOURCE: Research and Markets

Research and Markets 
Laura Wood, Senior Manager 
press@researchandmarkets.com 
For E.S.T Office Hours Call 1-917-300-0470 
For U.S./CAN Toll Free Call 1-800-526-8630 
For GMT Office Hours Call +353-1-416-8900 
Related Topics: Animal Healthcare/Veterinary

Copyright Business Wire 2017

Please read the End User Agreement.
By accessing this page, you agree to the terms and conditions of the End User Agreement.

News provided by COMTEX.

Lt Crude 57.10
Nat Gas 3.015
Corn 345
Cotton #2 70.14
Gold 1280.1
Copper 3.1295
Euro 1.17535
USD Index 93.877
SP500 E-mini 2596.00
DJIA E-mini 23543
close_icon
open_icon